Tumor microenvironment responsive biomimetic copper peroxide nanoreactors for drug delivery and enhanced chemodynamic therapy

Shengxin Hou,Yong-E Gao,Xianbin Ma,Yi Lu,Xinyi Li,Jiaqi Cheng,Yongqiong Wu,Peng Xue,Yuejun Kang,Mingming Guo,Zhigang Xu

DOI: https://doi.org/10.1016/j.cej.2021.129037

IF: 15.1

2021-07-01

Chemical Engineering Journal

Abstract:<p>Facing the multiple and arduous characteristics of tumors, chemodynamic therapy (CDT) is an emerging therapeutic approach. It uses toxic hydroxyl radical (∙OH) produced by Fenton reaction to induce cell apoptosis, which is not restricted by other factors such as the limitations of tissue depth and hypoxic tumor microenvironment. However, the problem of insufficient endogenous hydrogen peroxide (H₂O₂) seriously restricts its development and widespread use. In this study we developed a new type of nano-Fenton catalyst SS-CuO₂@Dox (SCD), which was prepared by the peroxidation reaction of Cu²⁺. Under the decoration of sericin, it had excellent hydrophilicity and biocompatibility, and could target the tumor regions via the enhanced permeability and retention (EPR) effect. It could be decomposed under the acidic conditions of the tumor microenvironment (TME) and endogenously released H₂O₂ and Cu²⁺, which enhanced the efficiency of the Fenton reaction. At the same time, the successful delivery of doxorubicin (Dox), a chemotherapeutic drug, realized the combination of chemotherapy and CDT, improving the therapeutic effect of tumor. The strategy of generating H₂O₂ in situ could solve the problem of insufficient H₂O₂ in tumor without causing damage to other tissues and organs. This treatment provided a new idea for enhanced CDT and synergistic therapy, showing a promising prospect of application.</p>

engineering, chemical, environmental

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the efficiency and effectiveness of chemodynamic therapy (CDT) in tumor treatment. Specifically, in view of the low catalytic efficiency in traditional CDT due to the insufficient concentration of endogenous hydrogen peroxide (H₂O₂) in the tumor microenvironment, the paper has developed a new type of nano - Fenton catalyst (SS - CuO₂@Dox, abbreviated as SCD). This catalyst can decompose under the acidic conditions of the tumor microenvironment, automatically generate H₂O₂, and release Cu²⁺ to efficiently catalyze the Fenton reaction, generating highly oxidizing hydroxyl radicals (∙OH), thereby enhancing apoptosis and achieving effective killing of tumors. In addition, SCD can also load the chemotherapeutic drug doxorubicin (Doxorubicin, Dox), further enhancing the treatment effect through the synergy of chemotherapy and CDT. This strategy not only solves the problem of insufficient H₂O₂ in the tumor microenvironment, but also avoids damage to other tissues and organs, providing new ideas for enhancing CDT and synergistic treatment.